While type 1 MIs continue to dominate, the prevalence of type 2 MIs has grown in recent years among Medicare beneficiaries, an observational study shows. The shift has implications for care, ...
Type 2 diabetes, linked to insulin resistance, affects a significant portion of the American population, many undiagnosed. Pre-diabetes, also caused by insulin resistance, often progresses to Type 2 ...
The approval of medicines called “glucagon-like peptide (GLP-1) agonists” has led to major changes in how type 2 diabetes is managed. These medicines work in a different way than other medicines used ...